Jeffrey S. Weber, MD, PhD, on Melanoma: Results of the CheckMate 238 Trial

2017 ESMO Congress
Tweet this page

Jeffrey S. Weber, MD, PhD, of New York University’s Langone Medical Center, discusses study results on adjuvant therapy with nivolumab vs ipilimumab after complete resection of stage III/IV melanoma (Abstract LBA8).

Advertisement

Advertisement



Advertisement